4//SEC Filing
Yarema Kristin 4
Accession 0001209191-20-015360
CIK 0001604464other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:00 PM ET
Size
5.1 KB
Accession
0001209191-20-015360
Insider Transaction Report
Form 4
Yarema Kristin
Chief Commercial Officer
Transactions
- Award
Common Stock
2020-03-01+55,000→ 55,000 total
Footnotes (1)
- [F1]These restricted stock units vest as to 25% of the shares on March 1, 2021 and the remaining shares vest in 12 equal quarterly installments on each Company Quarterly Vesting Date (as defined below) following March 1, 2021, subject to the reporting person's continuous service. Company Quarterly Vesting Date means March 1, May 15, August 15 and November 15 of each year.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001803794
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:00 PM ET
- Size
- 5.1 KB